Summary
Pitavastatin (usually as a calcium salt) is a member of the blood cholesterol lowering medication class of statins, marketed in the United States under the trade name Livalo, and in European Union and Russia under the trade name Livazo. Like other statins, it is an inhibitor of HMG-CoA reductase, the enzyme that catalyses the first step of cholesterol synthesis.
The global Pitavastatin market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major Application
Global market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
Kowa Pharmaceuticals
CR Double-Crane Pharmaceuticals
Major applications as follows:
Hypercholesterolaemia
Cardiovascular Disease
Diabetes
Others
Major Type as follows:
1 mg
2 mg
5 mg
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Summary:
Get latest Market Research Reports on Pitavastatin . Industry analysis & Market Report on Pitavastatin is a syndicated market report, published as Global Pitavastatin Market Data Survey Report 2013-2025. It is complete Research Study and Industry Analysis of Pitavastatin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.